Englewood Lab Inc (950140) - Total Assets
Based on the latest financial reports, Englewood Lab Inc (950140) holds total assets worth ₩230.10 Billion KRW (≈ $155.93 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Englewood Lab Inc (950140) net assets for net asset value and shareholders' equity analysis.
Englewood Lab Inc - Total Assets Trend (2015–2024)
This chart illustrates how Englewood Lab Inc's total assets have evolved over time, based on quarterly financial data.
Englewood Lab Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Englewood Lab Inc's total assets of ₩230.10 Billion consist of 73.5% current assets and 26.5% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩19.13 Million | 0.0% |
| Accounts Receivable | ₩61.95 Billion | 45596.3% |
| Inventory | ₩27.30 Million | 20.1% |
| Property, Plant & Equipment | ₩30.14 Million | 22.2% |
| Intangible Assets | ₩936.89K | 0.7% |
| Goodwill | ₩127.45K | 0.1% |
Asset Composition Trend (2015–2024)
This chart illustrates how Englewood Lab Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Englewood Lab Inc market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Englewood Lab Inc's current assets represent 73.5% of total assets in 2024, an increase from 53.6% in 2015.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2024, down from 1.9% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2015.
- Asset Diversification: The largest asset category is accounts receivable at 45596.3% of total assets.
Englewood Lab Inc Competitors by Total Assets
Key competitors of Englewood Lab Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Silicon2 Co. Ltd.
KQ:257720
|
Korea | ₩668.12 Billion |
|
Guangdong Marubi Biotechnology Co
SHG:603983
|
China | CN¥4.85 Billion |
|
Profit Cultural & Creative Group Co Ltd
SHE:300640
|
China | CN¥1.12 Billion |
|
Kolmar BNH Co. Ltd
KQ:200130
|
Korea | ₩649.69 Billion |
|
Amorepacific Group
KO:002795
|
Korea | ₩8.54 Trillion |
|
Hankook Cosmet
KO:123690
|
Korea | ₩57.42 Billion |
|
KP Tissue Inc
TO:KPT
|
Canada | CA$71.60 Million |
|
Suominen Oyj
HE:SUY1V
|
Finland | €278.77 Million |
Englewood Lab Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.84 | 3.06 | 2.18 |
| Quick Ratio | 2.14 | 2.17 | 1.11 |
| Cash Ratio | 0.00 | 0.52 | 0.00 |
| Working Capital | ₩115.83 Billion | ₩67.42 Million | ₩36.70 Billion |
Englewood Lab Inc - Advanced Valuation Insights
This section examines the relationship between Englewood Lab Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.64 |
| Latest Market Cap to Assets Ratio | 1.19 |
| Asset Growth Rate (YoY) | 0.9% |
| Total Assets | ₩135.87 Million |
| Market Capitalization | $161.57 Million USD |
Valuation Analysis
Above Book Valuation: The market values Englewood Lab Inc's assets above their book value (1.19x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: Englewood Lab Inc's assets grew by 0.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Englewood Lab Inc (2015–2024)
The table below shows the annual total assets of Englewood Lab Inc from 2015 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩135.87 Million ≈ $92.08K |
+0.90% |
| 2023-12-31 | ₩134.67 Million ≈ $91.26K |
+26.06% |
| 2022-12-31 | ₩106.82 Million ≈ $72.39K |
-1.20% |
| 2021-12-31 | ₩108.12 Million ≈ $73.27K |
+8.21% |
| 2020-12-31 | ₩99.92 Million ≈ $67.72K |
+0.30% |
| 2019-12-31 | ₩99.62 Million ≈ $67.51K |
+6.31% |
| 2018-12-31 | ₩93.71 Million ≈ $63.50K |
+8.60% |
| 2017-12-31 | ₩86.29 Million ≈ $58.47K |
+23.46% |
| 2016-12-31 | ₩69.89 Million ≈ $47.36K |
-99.85% |
| 2015-12-31 | ₩46.21 Billion ≈ $31.32 Million |
-- |
About Englewood Lab Inc
Englewood Lab, Inc. engages in the research, development, manufacture, and sale of cosmetic products in the United States, Korea, Canada, China, Japan Europe, and internationally. It offers masks, cleansers, and anti-aging skincare products, as well as face, eye, and body moisturizer; primers and foundations, BB and CC Cream, concealer, blush and illuminizers, bronzer highlighter, and lip care; a… Read more